Your session is about to expire
← Back to Search
Mifepristone for Pregnancy and Miscarriage
Study Summary
This trial will test if it's feasible to mail abortion medication to patients, who will then take it at home.
- Pregnancy
- Miscarriage
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 4 trial • 8 Patients • NCT01990560Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are willing and able to participate in the study, including willing and able to receive medications at home or other preferred address within 3 days of initial medication abortion visit.You do not want to have a medication-induced abortion.You cannot take medication to end a pregnancy.
- Group 1: Medication Abortion Patients
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How widely distributed is this clinical trial?
"To date, enrolment for this trial is taking place across a variety of locations such as Lifespan in Providence, Pennsylvania, Allegheny Reproductive Health Center in Pittsburgh and Planned Parenthood Rocky Mountains in Denver. Additionally, there are numerous other sites enrolling patients."
What medical ailments is Mifepristone typically utilized to address?
"Mifepristone is an effective therapeutic agent for treating hyperglycemia, as well as medical procedures such as abortion."
Are new participants being welcomed into this medical experiment?
"As reported on clinicaltrials.gov, this medical trial is inactive in terms of participant recruitment. First posted on May 1st 2020 and last updated July 8th 2022, there are no enrolment opportunities for prospective patients at the moment; however, 148 other trials remain open to participants."
What is the current regulatory status of Mifepristone?
"Mifepristone has already been approved for use, so it is assigned a safety score of 3."
What other research initiatives have been conducted on Mifepristone?
"Research into the efficacy of mifepristone began in 2016 at Integrated Program for Substance Abuse Research, and has since culminated in 85 trials. At present, 10 clinical studies are underway with a generous portion of these being conducted from Providence, Pennsylvania."
How many participants have been accepted into the research initiative thus far?
"This study is no longer open for recruitment. It was first listed on the 5th of January 2020 and last updated on 8th July 2022. However, there are currently 138 studies concerning early abortion that require participants, with 10 trials dedicated to Mifepristone specifically searching for volunteers."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger